The Patient-Controlled Analgesia Pumps Market is projected to generate US$ 421.9 million in 2022 and US$ 699.9 million by 2032, expanding at a CAGR of 5.2%. According to a new estimate by Future Market Insights, PCA pumps will command the market globally in 2021 with a share of around 75.5%. The market for patient-controlled analgesia pumps is anticipated to expand rapidly over the forecast period and will likely be worth more than US$ 500 million by the end of the forecast year.
Analgesics can be self-administered by patients using PCA or patient-controlled analgesia pumps as and when necessary. Patient-controlled analgesia pumps are not utilised to treat long term pains. PCA is employed in a variety of settings, including pediatrics, gastrointestinal, hematological, cancer, and diabetes. The use of PCA has a number of advantages. It enables total control over the management of pain. Additionally, it helps to stop blood clots from forming and speeds up healing.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5710
However, there are certain disadvantages, the main aspect being an occurrence of an over dost or an under dose that can take place in case of improper settings and programming of the device. Government initiatives to boost home medication, rising awareness about patient-controlled analgesia pumps, and affordable costs are few of the aspects contributing to the expansion of patient-controlled analgesia pumps market at a global level.
Global Patient-Controlled Analgesia Pumps Market: Dynamics
The growth of the global patient-controlled analgesia pumps market is influenced by aspects such as various advantages of PCA system over conventional continuous infusion systems, increasing standardization for reducing costs in hospitals, development of quality indicators for patient-controlled analgesia pumps, modernization with a view to reduce errors, increasing adoption of PCA owing to increasing prevalence of cancer, pain and diabetes, rising forward integration and increasing demand for PCA in rental and homecare services.
Ask Us Your Questions About This Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-5710
These factors have contributed to the growth of the global market. On the contrary, lack of skilled manpower and lack of standard usage guidelines and vast product recalls are hampering the growth of the global patient-controlled analgesia pumps market. Various trends have been observed, to name a few, rapid med-tech progress, shifting production base to emerging economies, user-friendly advanced equipment and fragmented market. Opportunities such as increasing production base for smart pumps with bigger drug libraries and expanding production base for PCA, ambulatory and other pumps have been boosting the growth of the global market.
Segmental Highlights
The global patient-controlled analgesia pumps market has been segmented by product type, by end user, by application and by region.
- By product type, the PCA pumps segment is estimated to be the largest segment in terms of market value and likely to lead the global market. it is also projected to grow at a higher pace thus reflecting high potential for growth of global market in the coming years
- By region, Asia Pacific excluding Japan (APEJ) region is projected to be the fastest growing with a high 9.6% CAGR during the forecast period. North America is the largest from a market share perspective
- By end user, hospitals segment is the most lucrative. This segment dominated the global market in 2017 and is expected to lead the market by 2026 end with a valuation of more than US$ 200 Mn
- By application, diabetes segment is the fastest growing segment with a high CAGR of 6.0% throughout the period of forecast.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-5710
The research report has also profiled various leading players in the global patient-controlled analgesia pumps market. Companies like Becton Dickinson and Company, Baxter International, B.Braun Melsungen AG, Terumo Corporation, Ace Medical Co. Ltd., Micrel Medical Devices, Hospira (Pfizer Inc.), Fresenius Kabi Group and Smiths Group plc., have been profiled in this research report.
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
๐ณ๐๐๐ ๐๐๐ ๐ ๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐, ๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐!
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ@ https://www.futuremarketinsights.com/checkout/5710
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Top Related Reports:
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware โ 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports